ALEMBIC
Quarterly Results Analysis [Dec2024]
ALEMBIC Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹58 Cr | ₹53 Cr | ₹51 Cr | ₹49 Cr | ₹39 Cr | ₹32 Cr | ₹37 Cr | ₹37 Cr |
Expenses | ₹32 Cr | ₹33 Cr | ₹30 Cr | ₹25 Cr | ₹28 Cr | ₹22 Cr | ₹26 Cr | ₹24 Cr |
Operating Income | ₹26 Cr | ₹20 Cr | ₹20 Cr | ₹24 Cr | ₹12 Cr | ₹10 Cr | ₹11 Cr | ₹13 Cr |
Other Income | ₹4 Cr | ₹66 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹48 Cr | ₹3 Cr | ₹2 Cr |
Interest | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹27 Cr | ₹82 Cr | ₹19 Cr | ₹24 Cr | ₹11 Cr | ₹56 Cr | ₹12 Cr | ₹3 Cr |
Profit After Tax | ₹26 Cr | ₹77 Cr | ₹17 Cr | ₹21 Cr | ₹10 Cr | ₹52 Cr | ₹10 Cr | ₹5 Cr |
EPS | ₹2.55 | ₹4.71 | ₹2.17 | ₹2.81 | ₹2.39 | ₹3.53 | ₹1.73 | ₹1.88 |
Industry Peers & Returns | 1W | 1M | 1Y |
ALEMBIC | -2.8% | 4.8% | 22.8% |
SUN PHARMACEUTICAL INDUSTRIES | -3.9% | 3% | 7.9% |
DIVIS LABORATORIES | -5% | -1.1% | 71.6% |
CIPLA | -4.4% | 0.2% | -1.7% |
TORRENT PHARMACEUTICALS | -1.6% | 6.5% | 26.2% |
DR REDDYS LABORATORIES | -2.4% | 2.4% | -5.4% |
MANKIND PHARMA | 2.4% | 7.1% | 3.9% |
ZYDUS LIFESCIENCES | -3.3% | -1% | -11.4% |
LUPIN | -5.4% | 3.4% | 26.8% |
ALEMBIC Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 9.47 % |
Y-o-Y | 47.30 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹58 Cr | 9.47 | |
Sep2024 | ₹53 Cr | 4.19 | |
Jun2024 | ₹51 Cr | 3.55 | |
Mar2024 | ₹49 Cr | 24.72 | |
Dec2023 | ₹39 Cr | 21.81 | |
Sep2023 | ₹32 Cr | -12.38 | |
Jun2023 | ₹37 Cr | -0.75 | |
Mar2023 | ₹37 Cr | - |
ALEMBIC Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 34.90 % |
Y-o-Y | 126.03 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹26 Cr | 34.90 | |
Sep2024 | ₹20 Cr | -4.07 | |
Jun2024 | ₹20 Cr | -15.53 | |
Mar2024 | ₹24 Cr | 106.76 | |
Dec2023 | ₹12 Cr | 15.07 | |
Sep2023 | ₹10 Cr | -6.62 | |
Jun2023 | ₹11 Cr | -19.18 | |
Mar2023 | ₹13 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 23.22 % |
Y-o-Y | 53.47 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 45.58% | 23.22 | |
Sep2024 | 36.99% | -7.92 | |
Jun2024 | 40.17% | -18.44 | |
Mar2024 | 49.25% | 65.82 | |
Dec2023 | 29.7% | -5.53 | |
Sep2023 | 31.44% | 6.54 | |
Jun2023 | 29.51% | -18.55 | |
Mar2023 | 36.23% | - |
ALEMBIC Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -66.25 % |
Y-o-Y | 163.00 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹26 Cr | -66.25 | |
Sep2024 | ₹77 Cr | 343.80 | |
Jun2024 | ₹17 Cr | -18.18 | |
Mar2024 | ₹21 Cr | 114.62 | |
Dec2023 | ₹10 Cr | -80.82 | |
Sep2023 | ₹52 Cr | 419.18 | |
Jun2023 | ₹10 Cr | 111.91 | |
Mar2023 | ₹5 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -69.18 % |
Y-o-Y | 78.52 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 45.04 % | -69.18 | |
Sep2024 | 146.12 % | 326.01 | |
Jun2024 | 34.3 % | -20.99 | |
Mar2024 | 43.41 % | 72.06 | |
Dec2023 | 25.23 % | -84.25 | |
Sep2023 | 160.19 % | 492.42 | |
Jun2023 | 27.04 % | 113.59 | |
Mar2023 | 12.66 % | - |
ALEMBIC Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -45.86 % |
Y-o-Y | 6.69 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹2.55 | -45.86 | |
Sep2024 | ₹4.71 | 117.05 | |
Jun2024 | ₹2.17 | -22.78 | |
Mar2024 | ₹2.81 | 17.57 | |
Dec2023 | ₹2.39 | -32.29 | |
Sep2023 | ₹3.53 | 104.05 | |
Jun2023 | ₹1.73 | -7.98 | |
Mar2023 | ₹1.88 | - |
You may also like the below Video Courses